Astellas Pharma Korea, Inc.
19 clinical trials · Sponsor
◉ Watch Astellas Pharma Korea, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Track the Safety of Vesomni in Men in South Korea Treated in Routine Clinical Practice for the Urinary Symptoms of Benign Prostatic Hyperplasia (Enlarged Prostate) (NCT07619105) | Astellas Pharma Korea, Inc. | 2026-09-30 |
| A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer. (NCT06902545) | Astellas Pharma Korea, Inc. | 2025-04-03 |
| Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients (NCT06452212) | Astellas Pharma Korea, Inc. | 2024-07-10 |
| A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection (NCT06011954) | Astellas Pharma Korea, Inc. | 2023-11-01 |
| A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA) (NCT03737708) | Astellas Pharma Korea, Inc. | 2019-02-13 |
Track Astellas Pharma Korea, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.